Developer of biosimilar theraputics
S. 3311 - American Made Pharmaceuticals Act of 2023 - Support for policies that encourage keeping the different elements of the prescription drug supply chain in the country to support better access to lifesaving medications and expand the number of quality jobs in the United States. Issues related to drug shortages in the United States and the role biosimilars can play. Issues related to cancer care and developing both biosimilar and novel treatments to fight disease. Issues related to advancing biosimilars in the health care market place to increase access and efficacy of life saving drugs. Support for encouraging the development, manufacturing and distribution of American-made biosimilars and other related products.
PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NATHANSON+HAUCK
601 13th Street NW, Suite 290 North, Washington, DC, 20005, US
MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON